Identifying patients with type 2 diabetes at high risk of microalbuminuria: Results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study

Nephrology Dialysis Transplantation

Volumn 23, Issue 4, 2008, Pages 1278-1284

  Rossi, Maria C E ^a   Nicolucci, Antonio ^a   Pellegrini, Fabio ^a   Comaschi, Marco ^b   Ceriello, Antonio ^c   Cucinotta, Domenico ^d   Giorda, Carlo ^e   Valentini, Umberto ^f   Vespasiani, Giacomo ^g   De Cosmo, Salvatore ^h  

^a Consorzio Mario Negri Sud ^*  (Italy)

^b Ospedale La Colletta   (Italy)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d UNIVERSITY OF MESSINA   (Italy)

^e Metabolism and Diabetes Unit ASL 8   (Italy)

^f Diabetologic Unit   (Italy)

^g Madonna del Soccorso Hospital   (Italy)

^h Unit of Endocrinology   (Italy)

Author keywords

Cardiovascular risk; Microalbuminuria; Prevalence; RECPAM analysis; Type 2 diabetes

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT CARE; PATIENT EDUCATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINARY TRACT INFECTION; WAIST CIRCUMFERENCE; ADOLESCENT; ALBUMINURIA; AWARENESS; BLOOD; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; HOSPITALIZATION; ITALY; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; REGRESSION ANALYSIS; RISK; RISK ASSESSMENT; URINE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; AWARENESS; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ITALY; MALE; MIDDLE AGED; ODDS RATIO; PATIENT EDUCATION AS TOPIC; PREVALENCE; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 42949152488     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm798     Document Type: Article

References (23)

1. Haffner SM, Lehto S, Ronnemaa T et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234
2. Molitch ME, DeFronzo RA, Franz MJ et al. American Diabetes Association: nephropathy in diabetes. Diabetes Care 2004; 27 (Suppl 1): S79-S83
3. Tobe SW, McFarlane PA, Naimark DM. Microalbuminuria in diabetes mellitus. CMAJ 2002; 167: 499-503
4. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997; 157: 1413-1418
5. Ochodnicky P, Henning RH, van Dokkum RP et al. Microalbuminuria and endothelial dysfunction: emerging targets for primary prevention of end-organ damage. J Cardiovasc Pharmacol 2006; 47 (Suppl 2): S151-S162
6. Retnakaran R, Cull CA, Thorne KI et al. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective diabetes study 74. Diabetes 2006; 55: 1832-1839
7. Grundy SM, Brewer HB, Cleeman JI et al. for the Conference Participants. Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004; 109: 433-438
8. The IDF consensus worldwide definition on the Metabolic Syndrome. http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf (p. 13)
9. Naushahi MJ, de Grauw WJ, Avery AJ et al. Risk factors for development of impaired renal function in type 2 diabetes mellitus patients in primary care. Diabet Med 2004; 21: 1096-1101
10. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO consultation. Geneva: World Health Organization, 1999
11. Clinical guidelines task force. Global guidelines for type 2 diabetes. International Diabetes Federation, 2005. http://www.idf.org/webdata/docs/ IDF%20GGT2D.pdf (p. 56)
12. Grundy SM, Cleeman JI, Bairey Merz CN et al. For the Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004; 110: 227-239
13. Nicolucci A, Carinci F, Ciampi A. Stratifying patients at risk of diabetic complications: an integrated look at clinical, socioeconomic, and care-related factors. SID-AMD Italian Study Group for the Implementation of the St. Vincent Declaration. Diabetes Care 1998; 21: 1439-1444
14. Ciampi A. Constructing prediction trees from data: the RECPAM approach. Proceedings from the Prague 1991 Summer School on Computational Aspects of Model Choice. Heidelberg: Physica-Verlag, 1992, 105-152
15. Dixon AN, Raymond NT, Mughal S et al. Prevalence of microalbuminuria and hypertension in South Asians and white Europeans with type 2 diabetes: a report from the United Kingdom Asian Diabetes Study (UKADS). Diab Vasc Dis Res 2006; 3: 22-25
16. Burnier M, Zanchi A. Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes. J Hypertens 2006; 24: 11-25
17. Parving HH, Lewis JB, Ravid M et al. DEMAND Investigators. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006; 69: 2057-2063
18. de Boer IH, Sibley SD, Kestenbaum B et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J Am Soc Nephrol. 2007; 18(1): 235-243
19. Chandie Shaw PK, Berger SP, Mallat M et al. Central obesity is an independent risk factor for albuminuria in nondiabetic South Asian Subjects. Diabetes Care Jul 2007; 30(7): 1840-1844
20. Molitch ME, Rupp D, Carnethon M. Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing type 1 diabetes. Diabetes Care 2006; 29: 78-82
21. Smulders YM, Rakic M, Stehouwer CD et al. Determinants of progression of microalbuminuria in patients with NIDDM. A prospective study. Diabetes Care 1997; 20: 999-1005
22. Gaede P, Parving HH, Pedersen O. Long-termeffects of intensive multifactorial treatment on total and cardiovascular mortality in patients with type 2 diabetes. Diabetologia 2007; 50 (Suppl 1): S4
23. Gansevoort RT, Verhave JC, Hillege HL et al. for the PREVEND Study Group. The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int 2005; 94 (Suppl): S28-S35